Form D · Biotechnology

RetinalGenix Technologies Inc.

Apollo Beach, FL · CIK 0001836295

Offering snapshot reported Feb 11, 2025 · SEC filing

Reported sold
$653K
Offering amount: $5M
Investors reported
30
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 23, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.33M$4.65MFeb 9, 2024: $4,650,000.00Feb 9, 2024Feb 11, 2025: $653,089.00Feb 11, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,650,000 → $653,089
  • Reported investors17 → 30

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 11, 2025Amendment$653,089-$3,996,911vs Feb 9, 202430SEC filing
Feb 9, 2024Initial$4,650,000No comparison17SEC filing
Jul 1, 2021Initial$45,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-504938

Source: Form D, filed Feb 11, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Virender Ahluwalia Executive
Herbert Gould Director
Jerry Katzman Director, Executive
Vinay Mehindru Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
409 Apollo Beach Blvd Suite 6
Apollo Beach, FL, 33572-2281